Dr. Mohammad Athar is an Associate Professor of genomic medicine at the Department of Medical Genetics and Science and Technology Unit, Umm Al-Qura University, Makkah, Saudi Arabia. Dr. Athar obtained his Ph.D. in Bioscience from the Jamia Millia Islamia, Delhi, India, in 2012. Human Molecular Genetics, Functional Genomics, and Molecular Medicine are the major disciplines of his area of research. His research interests focus on inherited disorders (familial hypercholesterolemia, polycystic kidney disease, haemophilia, and thrombophilia) using cutting-edge genetic and genomic technologies such as Next-generation sequencing (NGS). Dr. Athar has over ten years of experience in a clinical research laboratory as a PI, Co-I, and Research Scientist on several national-level research grants. Dr. Athar contributed significantly to establishing the genetics spectrum of familial hypercholesterolemia in Saudi populations, in addition to developing high throughput, cost-effective Next-generation Sequencing (NGS) based methods for the molecular diagnosis of inherited disorders.
Dr. Mohammad Athar is an Associate Professor of genomic medicine at the Department of Medical Genetics and Science and Technology Unit, Umm Al-Qura University, Makkah, Saudi Arabia. Dr. Athar obtained his Ph.D. in Bioscience from the Jamia Millia Islamia, Delhi, India, in 2012. Human Molecular Genetics, Functional Genomics, and Molecular Medicine are the major disciplines of his area of research. His research interests focus on inherited disorders (familial hypercholesterolemia, polycystic kidney disease, haemophilia, and thrombophilia) using cutting-edge genetic and genomic technologies such as Next-generation sequencing (NGS). Dr. Athar has over ten years of experience in a clinical research laboratory as a PI, Co-I, and Research Scientist on several national-level research grants. Dr. Athar contributed significantly to establishing the genetics spectrum of familial hypercholesterolemia in Saudi populations, in addition to developing high throughput, cost-effective Next-generation Sequencing (NGS) based methods for the molecular diagnosis of inherited disorders.